Your cart is empty.
Tecan's Regulatory Affairs (RA) team has invested in a new market intelligence infrastructure that will keep our product development teams, business units and worldwide sales organizations, as well as our customers, fully up-to-date with regulatory information as it changes.
Innovative drug discovery company Siena Biotech, based in Italy, has chosen four highly tailored Freedom EVO® systems for different roles within the company and each one has been invaluable in increasing throughput and accuracy in testing compounds as potential therapeutic drugs.
The Japan Agency for Marine-Earth Science and Technology (JAMSTEC) is involved in a wide range of basic marine-related research, including observation and projection of the earth's environment, inner earth dynamics research and study of marine life in extreme environments.
Scientists from Affymetrix, Inc., a world-leading supplier of microarray equipment and assays, evaluated the Tecan Infinite® 200 NanoQuant multimode microplate reader and two other spectrophotometers for DNA concentration analysis in a new cytogenetic assay they have developed.
The Korea Center for Disease Control and Prevention (KCDC) in Seoul, Korea, conducts research to identify the etiology of communicable diseases and to find effective control, prevention, diagnosis and treatment for them.
The Biomolecular Separation Engineering group at the Karlsruhe Institute of Technology, Germany, is using the Freedom EVO® liquid handling workstation, equipped with the new Te-Chrom™ module and Atoll's 96-array MediaScout® RoboColumn system, to create a fully automated chromatography platform for biopharmaceutical process development.